Johnson And Johnson

• J&J’s COVID-19 vaccine restricted by FDA due to rare but serious blood clot risk

  U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

  Health

  May 5
  
• U.S. First Nations win $590M from drug companies in opioid epidemic lawsuit settlement

  Under the settlement, Johnson & Johnson agreed to pay $150 million over two years and the three largest U.S. drug distributors will pay nearly $440 million over seven years.

  World

  Feb 2
  
• Advertisement
• Canada grants full approval to Johnson & Johnson’s COVID-19 shot

  Johnson and Johnson's COVID-19 vaccine was previously authorized by the country under an interim order.

  Health

  Nov 24, 2021
• Advertisement
• COVID-19 vaccine maker Johnson & Johnson splitting into two companies

  Johnson & Johnson, a medical manufacturing titan and COVID-19 vaccine maker, has announced it is dividing its business into two companies for better market impact.

  World

  Nov 12, 2021
• Middlesex London Health Unit extends eligibility for COVID-19 booster shots

  This comes after the Ontario government announced Wednesday that it was extending eligibility for booster doses of a COVID-19 vaccine.

  Health

  Nov 3, 2021
• U.S. CDC approves Moderna, J&J COVID-19 vaccine boosters, along with mixing of shots

  The Food and Drug Administration had already authorized such an expansion of the nation's booster campaign on Wednesday, and it was also endorsed Thursday by a CDC advisory panel.

  Health

  Oct 21, 2021
• Johnson & Johnson eyes US$2.5B in COVID-19 vaccine sales despite Q3 slide

  Johnson & Johnson said it recorded US$766 million in sales of the shot in the first nine months of 2021, and would need sales to triple in the fourth quarter to meet its target.

  Money

  Oct 19, 2021
• Johnson and Johnson seeking FDA clearance on COVID-19 vaccine booster

  J&J said it filed a request with the FDA to authorize boosters for people who previously received the company's one-shot vaccine.

  Health

  Oct 5, 2021
• Advertisement
• Pfizer claims third vaccine dose increases protection against COVID-19 Delta variant

  Pfizer gained a head start in December with the first U.S. emergency authorization of a COVID-19 vaccine, and has since jumped ahead of rivals.

  World

  Jul 28, 2021
• Advertisement
• U.S. lawsuit accusing companies of fuelling opioid crisis may be settled for $26 billion

  The lawsuit against drugmaker Johnson & Johnson and the nation's three biggest drug distribution companies could see the biggest settlement in the history of opioid litigation.

  Health

  Jul 20, 2021